BBIO

BridgeBio Pharma
D

BBIO

67.120
USD
2.16
(3.32%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
141,525
الربح لكل سهم
-2
العائد الربحي
-
P/E
-19
حجم السوق
13,121,489,959
أصول ذات صلة

العنوان: BridgeBio Pharma

القطاع: الرعاية الصحية
الصناعة: Biotechnology
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.